INTERNATIONAL PATENT: CARDIOMIX S.R.L. FILES APPLICATION FOR "AUTOANTIBODIES AGAINST NAV1.5 CHANNEL AS BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME"

GENEVA, Feb. 3 -- CARDIOMIX S.R.L. (Via Arrigo Boito, 820121 Milan) filed a patent application (PCT/EP2024/071047) for "AUTOANTIBODIES AGAINST NAV1.5 CHANNEL AS BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME" on Jul 24, 2024. With publication no. WO/2025/021888, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANASTASIA, Luigi (c/o CARDIOMIX s.r.l.Via Arrigo Boito, 820121 MILANO), TARANTINO, Adriana (c/o CARDIOMIX S.r.l.Via Arrigo Boito, 820121 Milan), GHIROLDI, Andrea (c/o CARDIOMIX S.r.l.Via Arrigo Boito, 820121 Milan)...